Pancreatic Cancer Research

Journal articleCancer Med2026

Factors Associated With Recurrence After Adjuvant Gemcitabine and Nab-Paclitaxel in Patients With Resected Pancreatic Ductal Adenocarcinoma.

Journal
Cancer Med
Published
November 2026

These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.

Try